The FDA didn’t outright reject the applying, but questioned for one more Phase three clinical trial, that can likely get two or three many years to finish and resubmit to the FDA. With Lykos heading back into the drafting board, who’s planning to choose the subsequent swing at FDA approval?President Biden has mainly been a steadfast ally, but h